Research ArticleArticle
Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1-O-β-Glucuronide
Manthena V. S. Varma, Jian Lin, Yi-an Bi, Emi Kimoto and A. David Rodrigues
Drug Metabolism and Disposition July 2015, 43 (7) 1108-1118; DOI: https://doi.org/10.1124/dmd.115.064303
Manthena V. S. Varma
Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
Jian Lin
Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
Yi-an Bi
Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
Emi Kimoto
Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
A. David Rodrigues
Pharmacokinetics Dynamics and Metabolism, Pfizer Global Research and Development, Pfizer Inc., Groton, Connecticut
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Quantitative Rationalization of Gemfibrozil DDIs
Manthena V. S. Varma, Jian Lin, Yi-an Bi, Emi Kimoto and A. David Rodrigues
Drug Metabolism and Disposition July 1, 2015, 43 (7) 1108-1118; DOI: https://doi.org/10.1124/dmd.115.064303
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement